Hepatitis B&C

After completing the course the learner will:

• be able to use the epidemiology of hepatitis B and C to assess the risk for an individual and use this to promote testing.
• be able to explain the treatments available for hepatitis C and their success rates.  
• be able to identify individuals who need to be engaged or re-engaged with hepatitis care.  
• be confident in communicating with patients around risk, testing and results.  
• be able to describe their own role in managing people living with chronic hepatitis whatever their stage of treatment.  

As of 2023, this course is supported by the UK Health Security Agency, an executive agency sponsored by the Department of Health and Social Care.

This course was originally developed in partnership with Gilead Sciences.